Article
Synergistic polymorphic interactions of phase II metabolizing genes and their association toward lung cancer susceptibility in North Indians.
International journal of environmental health research - 1 Jan 2024
Walia Harleen Kaur, Sharma Parul, Singh Navneet, Sharma Siddharth
Abstract excerpt
Lung cancer is a multifactorial carcinoma with diverse heterogeneity. Genetic variations in drug-metabolizing enzymes may lead to defective detoxification and clearance of carcinogenic compounds. The high-order gene-gene interaction has been carried out between different genotypes of Phase II detoxification genes (NQO1, SULT1A1, NAT2, and EPHX1). Our results depict the genetic combination of SULT1A1 R213H with...
Topics
- Humans
- Arylamine N-Acetyltransferase
- Case-Control Studies
- Genotype
- Lung Neoplasms
- Polymorphism, Genetic
- Risk
